Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane + Cisplatin in Metastatic Breast Cancer
NCT01149798Phase 2Completed
- Sponsor
- Fudan University
- Start
- Jun 2010
- Primary completion
- Jun 2011
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in breast cancer, sponsored by Fudan University. Started Jun 2010; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01149798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01149798.